Beam Therapeutics Inc (BEAM)

R&D Expenses

$408.66M

TTM · Period ending: · USD

BEAM logo

BEAM R&D Expenses

Latest reported$408.66M
BEAM TTM R&D Expenses ($33.87M → $408.66M)
High-resolution chart · PNG

BEAM r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Beam Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
408,664,000
415,326,000
409,618,000
411,787,000
396,276,000
381,559,000
367,561,000
406,194,000
411,986,000
422,553,000
437,381,000
383,645,000
368,882,000
345,830,000
311,594,000
322,034,000
291,370,000
262,391,000
387,087,000
322,757,000
297,959,000
271,736,000
103,179,000
90,945,000
73,663,000
66,989,000
54,619,000
44,254,000
41,565,000
35,968,500
33,873,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.